Possible for CRISPR-edited plants: Little margin for optimism?

This article addresses the scenarios that may be encountered by the first application for pre-market approval of a CRISPR-edited plant in the EU. Two alternative scenarios are considered in the short and medium term. One of these possible EU futures depends on the final drafting and approval of EU legislation on certain New Genomic Techniques, which was started in 2021 and is due to be quite advanced before the next European Parliament elections in 2024.

[Revocation of authorizations on GMO under the precautionary principle (with special attention to the Justice Tribunal of the European Communities].

During the last decade, the european institutions have done a great effort in order to introduce the precautionary principle, applicable to the management of serious and uncertain risks. Under the protection of the precautionary principle, european authorities and authorities of the member states have partially modified, suspended or revoked authorizations relative to genetically modified organisms. Is it rightful this use of the precautionary principle? This is the matter that the European Communities Justice Court has faced when the affected companies have lodge their appeals against this decisions.